These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38399539)

  • 1. Irreversible Electroporation of the Hepatobiliary System: Current Utilization and Future Avenues.
    Narayanan G; Koethe Y; Gentile N
    Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible electroporation for the ablation of liver tumors: are we there yet?
    Charpentier KP
    Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous Irreversible Electroporation (IRE) of Hepatic Malignancy: A Bi-institutional Analysis of Safety and Outcomes.
    Mafeld S; Wong JJ; Kibriya N; Stenberg B; Manas D; Bassett P; Aslam T; Evans J; Littler P
    Cardiovasc Intervent Radiol; 2019 Apr; 42(4):577-583. PubMed ID: 30465255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is irreversible electroporation safe and effective in the treatment of hepatobiliary and pancreatic cancers?
    Wu LM; Zhang LL; Chen XH; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):117-124. PubMed ID: 30655073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the irreversible electroporation in the hepato-pancreatico-biliary surgery.
    Sánchez-Velázquez P; Clavien PA
    Cir Esp; 2017; 95(6):307-312. PubMed ID: 28318494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible electroporation (Nanoknife® treatment) in the field of hepatobiliary surgery: Current status and future perspectives.
    Kourounis G; Paul Tabet P; Moris D; Papalambros A; Felekouras E; Georgiades F; Astras G; Petrou A
    J BUON; 2017; 22(1):141-149. PubMed ID: 28365947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible Electroporation for Colorectal Liver Metastases.
    Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the irreversible electroporation for the treatment of liver metastases: When to use it.
    Belfiore MP; De Chiara M; Reginelli A; Clemente A; Urraro F; Grassi R; Belfiore G; Cappabianca S
    Front Oncol; 2022; 12():943176. PubMed ID: 36119531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation with irreversible electroporation in patients with advanced perihilar cholangiocarcinoma (ALPACA): a multicentre phase I/II feasibility study protocol.
    Coelen RJS; Vogel JA; Vroomen LGPH; Roos E; Busch ORC; van Delden OM; Delft FV; Heger M; van Hooft JE; Kazemier G; Klümpen HJ; van Lienden KP; Rauws EAJ; Scheffer HJ; Verheul HM; Vries J; Wilmink JW; Zonderhuis BM; Besselink MG; van Gulik TM; Meijerink MR
    BMJ Open; 2017 Sep; 7(9):e015810. PubMed ID: 28864693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible electroporation: state of the art.
    Wagstaff PG; Buijs M; van den Bos W; de Bruin DM; Zondervan PJ; de la Rosette JJ; Laguna Pes MP
    Onco Targets Ther; 2016; 9():2437-46. PubMed ID: 27217767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Irreversible electroporation: a new form of image-guided tumour ablation].
    Scheffer H; Nielsen K; van Tilborg A; Vieveen JM; van den Tol MP; Meijerink MR
    Ned Tijdschr Geneeskd; 2014; 158():A7176. PubMed ID: 24518847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
    Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
    BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible Electroporation in Hepatopancreaticobiliary Tumours.
    Ruarus AH; Vroomen LGPH; Puijk RS; Scheffer HJ; Zonderhuis BM; Kazemier G; van den Tol MP; Berger FH; Meijerink MR
    Can Assoc Radiol J; 2018 Feb; 69(1):38-50. PubMed ID: 29458954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Frequency Irreversible Electroporation: Safety and Efficacy of Next-Generation Irreversible Electroporation Adjacent to Critical Hepatic Structures.
    Siddiqui IA; Kirks RC; Latouche EL; DeWitt MR; Swet JH; Baker EH; Vrochides D; Iannitti DA; Davalos RV; McKillop IH
    Surg Innov; 2017 Jun; 24(3):276-283. PubMed ID: 28492356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible electroporation in primary and metastatic hepatic malignancies: A review.
    Lyu T; Wang X; Su Z; Shangguan J; Sun C; Figini M; Wang J; Yaghmai V; Larson AC; Zhang Z
    Medicine (Baltimore); 2017 Apr; 96(17):e6386. PubMed ID: 28445252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible electroporation for liver cancer ablation: A meta analysis.
    Yu M; Li S
    Eur J Surg Oncol; 2022 Jun; 48(6):1321-1330. PubMed ID: 35012834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible electroporation versus radiofrequency ablation for hepatocellular carcinoma: a single centre propensity-matched comparison.
    Freeman E; Cheung W; Ferdousi S; Kavnoudias H; Majeed A; Kemp W; Roberts SK
    Scand J Gastroenterol; 2021 Aug; 56(8):942-947. PubMed ID: 34057003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Meijerink MR; Ruarus AH; Vroomen LGPH; Puijk RS; Geboers B; Nieuwenhuizen S; van den Bemd BAT; Nielsen K; de Vries JJJ; van Lienden KP; Lissenberg-Witte BI; van den Tol MP; Scheffer HJ
    Radiology; 2021 May; 299(2):470-480. PubMed ID: 33724066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy.
    Simmerman E; Chung J; Lawson A; Kruse E
    J Surg Res; 2020 Feb; 246():260-268. PubMed ID: 31610354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer cells ablation with irreversible electroporation.
    Miller L; Leor J; Rubinsky B
    Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.